A clinical trial of Varoglutamstat in China
Latest Information Update: 29 Apr 2024
At a glance
- Drugs Varoglutamstat (Primary)
- Indications Alzheimer's disease
- Focus First in man; Therapeutic Use
- 24 Apr 2024 According to a Vivoryon Therapeutics media release, it is expected that the first human clinical trial in mainland China will not start before further clarity from an in-depth analysis of the VIVIAD results as well as from additional analysis of the full data and its implications
- 20 Dec 2021 New trial record
- 14 Dec 2021 According to a Simcere Pharmaceutical Group media release, clinical trial application for SIM0408 (Varoglutamstat) has been accepted for review by China CDE.